# Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers

> **NCT05153304** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of California, San Diego**

## Conditions studied

- Cancer of Gastrointestinal Tract

## Interventions

- **BIOLOGICAL:** personalized vaccine
- **DRUG:** Nivolumab

## Key facts

- **NCT ID:** NCT05153304
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-06
- **Primary completion:** 2026-06
- **Final completion:** 2027-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** funding
- **Last updated:** 2024-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05153304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05153304, "Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05153304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*